girocitinib   Click here for help

GtoPdb Ligand ID: 13208

Synonyms: Example 4 [US10738060]
Compound class: Synthetic organic
Comment: The chemical structure for girocitinib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a Janus kinase inhibitor with anti-inflammatory potential. It is one of the structures claimed in patent US10738060 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 90.44
Molecular weight 326.35
XLogP 0.26
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H](C1=NC2=CN=C3C=COC3=C2N1[C@H]4CC[C@H](CC#N)OC4)O
Isomeric SMILES O[C@H](C)C1=NC=2C(=C3C(=NC2)C=CO3)N1[C@H]4CC[C@@H](OC4)CC#N
InChI InChI=1S/C17H18N4O3/c1-10(22)17-20-14-8-19-13-5-7-23-16(13)15(14)21(17)11-2-3-12(4-6-18)24-9-11/h5,7-8,10-12,22H,2-4,9H2,1H3/t10-,11+,12-/m1/s1
InChI Key ZFQNHUSKKDBFHY-GRYCIOLGSA-N
References
1. Liang C. (2020)
JAK1 selective inhibitors and uses thereof.
Patent number: US10738060B2. Assignee: Hangzhou Highlightll Pharmaceutical Co Ltd, Tll Pharmaceutical LLC. Priority date: 30/09/2017. Publication date: 11/08/2020.